These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 39348473)

  • 1. Research Progress of γδT Cells in Tumor Immunotherapy.
    Li Y; Mo XP; Yao H; Xiong QX
    Cancer Control; 2024; 31():10732748241284863. PubMed ID: 39348473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in γδT cell engineering: paving the way for enhanced cancer immunotherapy.
    Yuan M; Wang W; Hawes I; Han J; Yao Z; Bertaina A
    Front Immunol; 2024; 15():1360237. PubMed ID: 38576617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic role of γδT cells in TNBC.
    Li W; Zhao X; Ren C; Gao S; Han Q; Lu M; Li X
    Front Immunol; 2024; 15():1420107. PubMed ID: 38933280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma delta (γδ) T cells in cancer immunotherapy; where it comes from, where it will go?
    Deng J; Yin H
    Eur J Pharmacol; 2022 Mar; 919():174803. PubMed ID: 35131312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From backstage to the spotlight: γδT cells in cancer.
    Wiesheu R; Coffelt SB
    Cancer Cell; 2024 Oct; 42(10):1637-1642. PubMed ID: 39270647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy.
    Song Y; Liu Y; Teo HY; Liu H
    Front Immunol; 2022; 13():914839. PubMed ID: 35747139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress of gammadelta T cell-based immunotherapy].
    Qiu FM; Li ZP; Huang J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):424-9. PubMed ID: 20731045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells.
    Liu K; Hoover AR; Wang L; Sun Y; Valerio TI; Furrer C; Adams J; Yang J; Li M; Chen WR
    Cancer Lett; 2024 Nov; 604():217267. PubMed ID: 39307410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dichotomous and stable gamma delta T-cell number and function in healthy individuals.
    Ou L; Wang H; Liu Q; Zhang J; Lu H; Luo L; Shi C; Lin S; Dong L; Guo Y; Huang L; Zhu J; Yin X; Huang AC; Karakousis G; Schuchter L; Amaravadi R; Zheng C; Fan Y; Guo W; Xu X
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of gamma/delta T cells for solid tumor immunotherapy.
    Zhu D; Ren X; Xie W; Chen J; Liang S; Jiang M; Wang J; Zheng Z
    Front Immunol; 2024; 15():1466266. PubMed ID: 39253082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture.
    Watanabe D; Koyanagi-Aoi M; Taniguchi-Ikeda M; Yoshida Y; Azuma T; Aoi T
    Stem Cells Transl Med; 2018 Jan; 7(1):34-44. PubMed ID: 29164800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma.
    Nakazawa T; Nakamura M; Park YS; Motoyama Y; Hironaka Y; Nishimura F; Nakagawa I; Yamada S; Matsuda R; Tamura K; Sugimoto T; Takeshima Y; Marutani A; Tsujimura T; Ouji N; Ouji Y; Yoshikawa M; Nakase H
    J Neurooncol; 2014 Jan; 116(1):31-9. PubMed ID: 24062140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy.
    Ferry GM; Agbuduwe C; Forrester M; Dunlop S; Chester K; Fisher J; Anderson J; Barisa M
    Front Immunol; 2022; 13():863155. PubMed ID: 35711450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumor.
    Takimoto R; Miyashita T; Mizukoshi E; Kamigaki T; Okada S; Ibe H; Oguma E; Naitoh K; Yasumoto K; Makita K; Tomita K; Goto S
    Cytotherapy; 2020 Jun; 22(6):329-336. PubMed ID: 32303429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem-epitope peptide: a novel stimulator for gammadeltaT cells in tumor immunotherapy.
    He X; Chen H; Wu D; Cui L; He W
    Cancer Lett; 2010 Feb; 288(1):86-93. PubMed ID: 19665289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of γδT cells in pregnancy and pregnancy-related complications.
    Xu QH; Liu H; Wang LL; Zhu Q; Zhang YJ; Muyayalo KP; Liao AH
    Am J Reprod Immunol; 2021 Nov; 86(5):e13487. PubMed ID: 34331364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological characteristics of γδT cells and application in tumor immunotherapy.
    Zhu R; Yan Q; Wang Y; Wang K
    Front Genet; 2022; 13():1077419. PubMed ID: 36685942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies.
    Sebestyen Z; Prinz I; Déchanet-Merville J; Silva-Santos B; Kuball J
    Nat Rev Drug Discov; 2020 Mar; 19(3):169-184. PubMed ID: 31492944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells.
    Paniagua-Herranz L; Díaz-Tejeiro C; Sanvicente A; Bartolomé J; Nieto-Jiménez C; Ocana A
    Front Immunol; 2024; 15():1432015. PubMed ID: 39144149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
    Li Y; Li G; Zhang J; Wu X; Chen X
    Front Immunol; 2020; 11():619954. PubMed ID: 33664732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.